GENZYME CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 39 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2009-12-08: Reporting owner BERTOLINI ROBERT J; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2009-11-23: Reporting owner TERMEER HENRI A; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-06: Reporting owner GERAGHTY JAMES A; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2009-11-06: Reporting owner GERAGHTY JAMES A; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2009-12-08 | BERTOLINI ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,125 7,125 owned after | $49.42 | 2009-12-10 | |
| 2009-11-23 | TERMEER HENRI A Director, Officer (Chmn, President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −200,000 200,000 owned after | $26.50 | 2009-11-25 | |
| 2009-11-06 | GERAGHTY JAMES A Officer (Senior Vice President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,800 0 owned after | $32.52 exercise price | 2009-11-10 | |
| 2009-11-06 | GERAGHTY JAMES A Officer (Senior Vice President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,075 0 owned after | $32.52 exercise price | 2009-11-10 | |
| 2009-05-21 | WIRTH PETER Officer (Exec VP,Legal & Corporate Dev.) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,750 42,750 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | MOSCICKI RICHARD A Officer (Sr VP,Chief Medical Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,038 23,038 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | Meeker David P Officer (ExecVP,Therapeutics,Biosurgery) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,750 42,750 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | GERAGHTY JAMES A Officer (Senior Vice President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,250 14,250 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | COONEY CHARLES L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | BERTHIAUME DOUGLAS A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | DesRosier Thomas Officer (Sr VP, General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,625 16,625 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,455 5,455 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | SYRON RICHARD F/CA Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | WYZGA MICHAEL S Officer (Executive VP and CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,750 42,750 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | SMITH SANDFORD D Officer (Exe VP,President Int'l Group) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,750 42,750 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | SMITH ALAN E Officer (Sr VP,Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,038 23,038 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | MCGILLICUDY CORNELIUS III Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | DZAU VICTOR J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | CSIMMA ZOLTAN A Officer (SrVP,Chief Human Resources Off) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,625 16,625 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | COLLIER EARL M JR Officer (Executive Vice President) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,750 42,750 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | BOUDREAUX GAIL Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | TERMEER HENRI A Director, Officer (Chmn, President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +190,000 190,000 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-21 | Bamforth Mark R Officer (Sr.VP, Corp. Operations & Phar) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,250 14,250 owned after | $58.66 exercise price | 2009-05-26 | |
| 2009-05-15 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,452 0 owned after | $20.59 exercise price | 2009-05-18 | |
| 2009-05-14 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 1,452 owned after | $20.59 exercise price | 2009-05-18 | |
| 2009-05-13 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 11,452 owned after | $20.59 exercise price | 2009-05-14 | |
| 2009-05-12 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,548 21,452 owned after | $20.59 exercise price | 2009-05-13 | |
| 2009-05-12 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,452 0 owned after | $11.47 exercise price | 2009-05-13 | |
| 2009-05-11 | CARPENTER ROBERT J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 7,452 owned after | $11.47 exercise price | 2009-05-13 | |
| 2009-01-16 | WIRTH PETER Officer (Exec VP,Legal & Corporate Dev.) | 4 | Genzyme NQ stock option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −232,180 0 owned after | $29.44 exercise price | 2009-01-20 | |
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ stock option (right to buy) Derivative · Direct | Holding | $135.25 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $46.24 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $48.38 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ stock option (right to buy) Derivative · Direct | Holding | $43.90 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $62.98 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $58.50 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $62.16 exercise price | 2009-01-06 | ||
| 2009-01-06 holding as of filing | Amello Jason Officer (CorpContrllr,ChiefAccntOfficer) | 3/A | Genzyme NQ Stock Option (right to buy) Derivative · Direct | Holding | $68.48 exercise price | 2009-01-06 |